https://doctransparency.com/doctor/fl/delray-beach/steven-goodman-1447351184
Medicare Enrolled

Dr. Steven Goodman, M.D.

Rheumatology · Delray Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
5130 LINTON BLVD, Delray Beach, FL 33484
5614950600
In practice since 2006 (19 years)
NPI: 1447351184 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goodman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goodman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goodman

Dr. Steven Goodman is a rheumatology in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Goodman performed 145,116 Medicare services across 7,801 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goodman received a total of $15,802 from 54 pharmaceutical and/or device companies across 859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goodman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 16% volume in FL$ $15,802 industry payments

Medicare Practice Summary

Medicare Utilization ↗
145,116
Medicare services
Top 16% in FL for rheumatology
7,801
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,638 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tocilizumab injection (Actemra)41,360$5$7
Certolizumab injection (Cimzia)27,400$4$12
Romosozumab injection (Evenity) for osteoporosis22,680$8$12
Denosumab injection (Prolia/Xgeva)18,660$18$25
Abatacept infusion (Orencia)6,150$34$75
Infliximab infusion (Remicade)5,930$26$100
Steroid injection (triamcinolone)4,348$1$10
Office visit, established patient (30-39 min)1,625$98$150
Blood draw (venipuncture)1,011$8$10
Calcium level, total928$5$8
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle899$59$100
Methotrexate sodium, 5 mg862$0$5
Blood creatinine level797$5$12
Urea nitrogen level to assess kidney function, quantitative793$4$12
Albumin (protein) level784$5$8
Bilirubin level, total782$5$12
Phosphatase (enzyme) level, alkaline782$5$15
Liver enzyme (sgot), level782$5$15
Liver enzyme (sgpt), level782$5$15
Uric acid level test640$4$8
Blood potassium level631$5$8
Complete blood count (CBC) with differential627$8$31
C-reactive protein test (inflammation marker)626$5$12
Blood sodium level625$5$12
Red blood cell sedimentation rate, to detect inflammation, non-automated594$4$12
Joint injection, major joint335$41$129
Administration of chemotherapy into vein, 1 hour or less317$108$250
Office visit, established patient (20-29 min)311$69$100
Vitamin D level test306$29$55
Measurement of antibody for assessment of autoimmune disorder, any method245$18$30
Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)188$181$277
Injection of trigger points, 1-2 muscles171$23$80
Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve157$84$240
Bone density scan (DEXA)156$39$125
Complete blood count (CBC), automated150$6$18
Administration of chemotherapy into vein, each additional hour139$23$75
Injection into tendon or ligament123$33$90
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve116$45$199
Analysis of substance using immunoassay technique, multiple step method100$11$20
New patient office visit (45-59 min)95$125$225
Cardiolipin antibody (tissue antibody) measurement79$25$40
X-ray of hand, minimum of 3 views74$29$50
Knee X-ray, 3 views71$32$55
Injection, zoledronic acid, 1 mg70$7$80
X-ray of lower and sacral spine, 2-3 views67$31$65
Shoulder X-ray, 2+ views64$28$50
Aspiration and/or injection of fluid from medium joint61$41$100
Screening test for autoimmune disorder58$12$25
Hip X-ray, 2-3 views56$35$60
Measurement of antibody for rheumatoid arthritis assessment55$13$25
Rheumatoid factor level50$6$25
X-ray of upper spine, 2-3 views42$30$60
Measurement of dna antibody, native or double stranded35$13$30
Measurement of dna antibody, single stranded34$12$20
Injection of anesthetic agent and/or steroid into rib nerve33$70$230
Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block33$26$340
Measurement of complement (immune system proteins), antigen,32$12$30
Measurement of complement function (immune system proteins)32$12$30
Injection into tendon at attachment to bone or muscle27$31$90
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less27$53$115
X-ray of wrist, minimum of 3 views25$34$55
Injection of carpal tunnel22$76$129
X-ray of middle spine, 3 views22$33$65
X-ray of ankle, 2 views16$26$45
X-ray of elbow, 2 views12$24$45
X-ray of both hips, 3-4 views12$44$75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.3% high complexity
80.7% medium
10.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,802
Total received (2018-2024)
Avg $2,257/year across 7 years
Top 31% in FL for rheumatology
54
Companies
859
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,779 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,631
2023
$2,433
2022
$2,061
2021
$2,245
2020
$1,503
2019
$2,242
2018
$2,687

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,280
GlaxoSmithKline, LLC.
$1,356
Novartis Pharmaceuticals Corporation
$1,329
UCB, Inc.
$1,046
ABBVIE INC.
$995
E.R. Squibb & Sons, L.L.C.
$982
PFIZER INC.
$962
Janssen Biotech, Inc.
$855
Boehringer Ingelheim Pharmaceuticals, Inc.
$566
Radius Health, Inc.
$560
Lilly USA, LLC
$413
AstraZeneca Pharmaceuticals LP
$410
Genentech USA, Inc.
$405
Mallinckrodt Hospital Products Inc.
$396
Mallinckrodt LLC
$316
AbbVie Inc.
$292
SANOFI-AVENTIS U.S. LLC
$266
AbbVie, Inc.
$262
Celgene Corporation
$238
Mallinckrodt Enterprises LLC
$186
GENZYME CORPORATION
$180
Sobi, Inc
$159
Alvogen Inc
$137
Horizon Therapeutics plc
$124
DePuy Synthes Sales Inc.
$113
SOBI, INC
$108
Aurinia Pharma U.S., Inc.
$90
Actelion Pharmaceuticals US, Inc.
$86
Alexion Pharmaceuticals, Inc.
$56
Fresenius Kabi USA, LLC
$52
Orthogenrx Inc.
$47
Ultragenyx Pharmaceutical Inc.
$44
Kyowa Kirin, Inc.
$42
Flexion Therapeutics, Inc.
$42
ANI Pharmaceuticals, Inc.
$34
West-Ward Pharmaceuticals
$33
Horizon Pharma plc
$30
Organon Llc
$29
Abbott Laboratories
$27
Hikma Pharmaceuticals USA
$26
Celltrion USA Inc.
$23
TerSera Therapeutics LLC
$22
SCILEX PHARMACEUTICALS INC.
$20
Cumberland Pharmaceuticals, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
Organon LLC
$17
Merck Sharp & Dohme Corporation
$15
MEDAC PHARMA, INC.
$14
Gilead Sciences, Inc.
$14
Eyevance Pharmaceuticals LLC
$13
Avion Pharmaceuticals
$12
Ironwood Pharmaceuticals, Inc
$12
Bioventus LLC
$11
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · Crysvita · DUZALLO · ETERNA · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN 3 · GenVisc 850 · HADLIMA · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · MONOVISC · Mitigare · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · SYNVISC-ONE · Seglentis · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ · YUFLYMA · ZTLido · Zerviate · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a rheumatology in Delray Beach?
Compare rheumatologys in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
58
Per 100K population
3.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Goodman is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Goodman experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Goodman performed 41,360 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goodman receive payments from pharmaceutical companies?
Yes. Dr. Goodman received a total of $15,802 from 54 companies across 859 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goodman's costs compare to other rheumatologys in Delray Beach?
Dr. Goodman's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goodman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →